✦ LIBER ✦

Tegaserod for dyspepsia and reflux symptoms in patients with chronic constipation: an exploratory open-label study

✍ Scribed by Juan Zeng; Xiu-Li Zuo; Yan-Qing Li; Wei Wei; Guo-Ping Lv

Book ID: 105921508
Publisher: Springer
Year: 2007
Tongue: English
Weight: 163 KB
Volume: 63
Category: Article
ISSN: 0031-6970
DOI: 10.1007/s00228-007-0287-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

An open-label study assessing the safety

An open-label study assessing the safety and efficacy of alitretinoin in patients with severe chronic hand eczema unresponsive to topical corticosteroids

✍ T. Dirschka; K. Reich; R. Bissonnette; J. Maares; T. Brown; T. L. Diepgen 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 206 KB

An open-label study of darbepoetin alfa

An open-label study of darbepoetin alfa administered once monthly for the maintenance of haemoglobin concentrations in patients with chronic kidney disease not receiving dialysis

✍ A. K. AGARWAL; M. R. SILVER; J. E. REED; R. K. DHINGRA; W. LIU; N. VARMA; C. STE 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 484 KB

Empirical treatment for the management o

Empirical treatment for the management of patients presenting with uninvestigated reflux symptoms: a prospective study in an Asian primary care population

✍ K. Y. Ho; K. A. Gwee; C. J. Khor; D. S. Selamat; C. T. Wai; K. G. Yeoh 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB

Safety, pharmacokinetics and efficacy of

Safety, pharmacokinetics and efficacy of factor VIIa formulated with PEGylated liposomes in haemophilia A patients with inhibitors to factor VIII – an open label, exploratory, cross-over, phase I/II study

✍ J. SPIRA; O. PLYUSHCH; N. ZOZULYA; R. YATUV; I. DAYAN; A. BLEICHER; M. ROBINSON; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 198 KB

Fentanyl buccal tablet for the treatment

Fentanyl buccal tablet for the treatment of breakthrough pain in opioid-tolerant patients with chronic cancer pain : A long-term, open-label safety study

✍ Sharon M. Weinstein; John Messina; Fang Xie 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 182 KB 👁 2 views

Demonstration of safety in Alzheimer's p

Demonstration of safety in Alzheimer's patients for intervention with an anti-hypertensive drug Nilvadipine: results from a 6-week open label study

✍ S. P. Kennelly; L. Abdullah; D. Paris; J. Parish; V. Mathura; M. Mullan; F. Craw 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 205 KB 👁 2 views

## Abstract ## Background Nilvadipine may lower rates of conversion from mild‐cognitive impairment to Alzheimer's disease (AD), in hypertensive patients. However, it remains to be determined whether treatment with nilvadipine is safe in AD patients, given the higher incidence of orthostatic hypote